Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance and Safety Assessment of HUMER STOP VIRUS Nasal Spray in Adults With Early Symptoms of Viral Respiratory Infection (COVID-19, Flu, Common Cold): an Open-label Randomized Controlled Study

NCT06278324 is registered in ClinicalTrials.gov with CEN Biotech as lead sponsor.

NCT NCT06278324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance and Safety Assessment of HUMER STOP VIRUS Nasal Spray in Adults With Early Symptoms of Viral Respiratory Infection (COVID-19, Flu, Common Cold): an Open-label Randomized Controlled Study
Lead sponsor
CEN Biotech
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2024
Completion date
May 16, 2025
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory tract infection, common cold, covid-19, flu, human